Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Covington
US Department of Justice
Chinese Patent Office
US Army
Julphar
Moodys
Chubb
Harvard Business School

Generated: November 17, 2018

DrugPatentWatch Database Preview

Aflibercept - Biologic Drug Details

« Back to Dashboard

Summary for aflibercept
Tradenames:1
Patents:62
Applicants:1
BLAs:1
Suppliers: see list1
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for aflibercept

US Patents for aflibercept

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Regeneron Pharmaceuticals EYLEA aflibercept INJECTABLE; INJECTION 125387 001 2011-11-18 ➤ Try a Free Trial Avalanche Australia Pty Ltd. (Southbank, AU) ➤ Try a Free Trial RX search
Regeneron Pharmaceuticals EYLEA aflibercept INJECTABLE; INJECTION 125387 001 2011-11-18 ➤ Try a Free Trial ➤ Try a Free Trial RX search
Regeneron Pharmaceuticals EYLEA aflibercept INJECTABLE; INJECTION 125387 001 2011-11-18 ➤ Try a Free Trial King Fahd University of Petroleum and Minerals (Dhahran, SA) King Saud University (Riyadh, SA) ➤ Try a Free Trial RX search
Regeneron Pharmaceuticals EYLEA aflibercept INJECTABLE; INJECTION 125387 001 2011-11-18 ➤ Try a Free Trial STC.UNM (Albuquerque, NM) ➤ Try a Free Trial RX search
Regeneron Pharmaceuticals EYLEA aflibercept INJECTABLE; INJECTION 125387 001 2011-11-18 ➤ Try a Free Trial King Fahd University of Petroleum and Minerals (Dhahran, SA) King Saud University (Riyadh, SA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for aflibercept

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1183353/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: AFLIBERCEPT; REGISTRATION NO/DATE: SWISSMEDIC 62397 29.10.2012
90020-4 Sweden ➤ Try a Free Trial PRODUCT NAME: AFLIBERCEPT; REG. NO/DATE: EU/1/12/797/001 20121122
00588 Netherlands ➤ Try a Free Trial PRODUCT NAME: AFLIBERCEPT; REGISTRATION NO/DATE: EU/1/12/797/001-002 20121122
13/016 Ireland ➤ Try a Free Trial PRODUCT NAME: AFLIBERCEPT; REGISTRATION NO/DATE: EU/1/12/797/001-002 20121122
0 Finland ➤ Try a Free Trial
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Deloitte
Moodys
Farmers Insurance
Federal Trade Commission
US Department of Justice
Medtronic
Chinese Patent Office
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.